CCL22 signaling contributes to sorafenib resistance in hepatitis B virus-associated hepatocellular carcinoma
Yanan Gao, Xing Fan, Nan Li, Chengzhi Du, Bin Yang, Wenhao Qin, Jing Fu, Geoffrey J. Markowitz, Hongyang Wang, Jianli Ma, Shuqun Cheng, Pengyuan Yang
Topics & Concepts
SorafenibHepatocellular carcinomaMedicineHepatitis B virusCancer researchCirrhosisHepatitis BImmunologyInternal medicineVirusHepatocellular Carcinoma Treatment and PrognosisHepatitis B Virus StudiesLiver physiology and pathology